nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—hypertension—obesity	0.386	1	CtDrD
Lisinopril—ACE—obesity	0.182	1	CbGaD
Lisinopril—Lisdexamfetamine—Methamphetamine—obesity	0.0931	0.365	CrCrCtD
Lisinopril—Nateglinide—Methamphetamine—obesity	0.083	0.326	CrCrCtD
Lisinopril—Aspartame—Methamphetamine—obesity	0.0789	0.309	CrCrCtD
Lisinopril—ACE2—bile—obesity	0.0105	0.274	CbGeAlD
Lisinopril—ACE—tunica intima—obesity	0.0038	0.0992	CbGeAlD
Lisinopril—ACE—sympathetic nervous system—obesity	0.00341	0.089	CbGeAlD
Lisinopril—ACE2—gall bladder—obesity	0.00292	0.0761	CbGeAlD
Lisinopril—ACE—autonomic nervous system—obesity	0.00229	0.0598	CbGeAlD
Lisinopril—ACE—arm—obesity	0.00203	0.0529	CbGeAlD
Lisinopril—ACE2—respiratory system—obesity	0.0018	0.0471	CbGeAlD
Lisinopril—ACE2—cardiovascular system—obesity	0.00138	0.0361	CbGeAlD
Lisinopril—ACE2—adipose tissue—obesity	0.00122	0.0318	CbGeAlD
Lisinopril—ACE2—digestive system—obesity	0.00115	0.0299	CbGeAlD
Lisinopril—ACE2—endocrine gland—obesity	0.000948	0.0247	CbGeAlD
Lisinopril—ACE2—liver—obesity	0.000855	0.0223	CbGeAlD
Lisinopril—ACE—respiratory system—obesity	0.00059	0.0154	CbGeAlD
Lisinopril—SLC15A1—digestive system—obesity	0.000523	0.0137	CbGeAlD
Lisinopril—Trandolapril—CES1—obesity	0.000502	0.196	CrCbGaD
Lisinopril—ACE—cardiovascular system—obesity	0.000452	0.0118	CbGeAlD
Lisinopril—SLC15A1—endocrine gland—obesity	0.000432	0.0113	CbGeAlD
Lisinopril—ACE—pituitary gland—obesity	0.0004	0.0104	CbGeAlD
Lisinopril—ACE—adipose tissue—obesity	0.000398	0.0104	CbGeAlD
Lisinopril—SLC15A1—liver—obesity	0.00039	0.0102	CbGeAlD
Lisinopril—Aspartame—TRPV1—obesity	0.000376	0.147	CrCbGaD
Lisinopril—ACE—digestive system—obesity	0.000375	0.00979	CbGeAlD
Lisinopril—ACE—adrenal gland—obesity	0.000357	0.00933	CbGeAlD
Lisinopril—ACE—endocrine gland—obesity	0.00031	0.00809	CbGeAlD
Lisinopril—ACE—liver—obesity	0.000279	0.00729	CbGeAlD
Lisinopril—ABCB1—islet of Langerhans—obesity	0.00022	0.00574	CbGeAlD
Lisinopril—ABCB1—respiratory system—obesity	0.000208	0.00542	CbGeAlD
Lisinopril—Fosinopril—ACE—obesity	0.000196	0.0767	CrCbGaD
Lisinopril—ABCB1—adrenal cortex—obesity	0.000174	0.00455	CbGeAlD
Lisinopril—ABCB1—cardiovascular system—obesity	0.000159	0.00415	CbGeAlD
Lisinopril—Spirapril—ACE—obesity	0.000158	0.0618	CrCbGaD
Lisinopril—Moexipril—ACE—obesity	0.000151	0.0593	CrCbGaD
Lisinopril—Benazepril—MTHFR—obesity	0.00015	0.0588	CrCbGaD
Lisinopril—ABCB1—pituitary gland—obesity	0.000141	0.00368	CbGeAlD
Lisinopril—Quinapril—ACE—obesity	0.000141	0.0551	CrCbGaD
Lisinopril—Cilazapril—ACE—obesity	0.000141	0.0551	CrCbGaD
Lisinopril—ABCB1—adipose tissue—obesity	0.00014	0.00366	CbGeAlD
Lisinopril—Trandolapril—ACE—obesity	0.000136	0.0534	CrCbGaD
Lisinopril—Ramipril—ACE—obesity	0.000136	0.0534	CrCbGaD
Lisinopril—Ramipril—BCHE—obesity	0.000136	0.0533	CrCbGaD
Lisinopril—ABCB1—digestive system—obesity	0.000132	0.00345	CbGeAlD
Lisinopril—ABCB1—adrenal gland—obesity	0.000126	0.00328	CbGeAlD
Lisinopril—Benazepril—ACE—obesity	0.000122	0.0479	CrCbGaD
Lisinopril—ABCB1—endocrine gland—obesity	0.000109	0.00285	CbGeAlD
Lisinopril—Enalapril—ACE—obesity	0.000103	0.0404	CrCbGaD
Lisinopril—ABCB1—liver—obesity	9.84e-05	0.00257	CbGeAlD
Lisinopril—Nateglinide—PPARG—obesity	7.68e-05	0.0301	CrCbGaD
Lisinopril—Mental disorder—Bupropion—obesity	7.54e-05	0.000838	CcSEcCtD
Lisinopril—Anxiety—Orlistat—obesity	7.54e-05	0.000837	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	7.51e-05	0.000834	CcSEcCtD
Lisinopril—Cough—Sibutramine—obesity	7.5e-05	0.000833	CcSEcCtD
Lisinopril—Malnutrition—Bupropion—obesity	7.5e-05	0.000832	CcSEcCtD
Lisinopril—Discomfort—Orlistat—obesity	7.47e-05	0.00083	CcSEcCtD
Lisinopril—Ataxia—Topiramate—obesity	7.46e-05	0.000828	CcSEcCtD
Lisinopril—Blood creatinine increased—Topiramate—obesity	7.43e-05	0.000825	CcSEcCtD
Lisinopril—Dry mouth—Orlistat—obesity	7.4e-05	0.000821	CcSEcCtD
Lisinopril—Flatulence—Bupropion—obesity	7.39e-05	0.00082	CcSEcCtD
Lisinopril—Dehydration—Topiramate—obesity	7.37e-05	0.000819	CcSEcCtD
Lisinopril—Tension—Bupropion—obesity	7.36e-05	0.000817	CcSEcCtD
Lisinopril—Dysgeusia—Bupropion—obesity	7.34e-05	0.000815	CcSEcCtD
Lisinopril—Arthralgia—Sibutramine—obesity	7.32e-05	0.000813	CcSEcCtD
Lisinopril—Chest pain—Sibutramine—obesity	7.32e-05	0.000813	CcSEcCtD
Lisinopril—Myalgia—Sibutramine—obesity	7.32e-05	0.000813	CcSEcCtD
Lisinopril—Anxiety—Sibutramine—obesity	7.29e-05	0.00081	CcSEcCtD
Lisinopril—Nervousness—Bupropion—obesity	7.28e-05	0.000808	CcSEcCtD
Lisinopril—Anaphylactic shock—Orlistat—obesity	7.25e-05	0.000805	CcSEcCtD
Lisinopril—Oedema—Orlistat—obesity	7.25e-05	0.000805	CcSEcCtD
Lisinopril—Back pain—Bupropion—obesity	7.25e-05	0.000805	CcSEcCtD
Lisinopril—Orthostatic hypotension—Topiramate—obesity	7.24e-05	0.000804	CcSEcCtD
Lisinopril—Discomfort—Sibutramine—obesity	7.23e-05	0.000803	CcSEcCtD
Lisinopril—Muscle spasms—Bupropion—obesity	7.21e-05	0.0008	CcSEcCtD
Lisinopril—Infection—Orlistat—obesity	7.2e-05	0.0008	CcSEcCtD
Lisinopril—Breast disorder—Topiramate—obesity	7.17e-05	0.000796	CcSEcCtD
Lisinopril—Dry mouth—Sibutramine—obesity	7.16e-05	0.000795	CcSEcCtD
Lisinopril—Toxic epidermal necrolysis—Topiramate—obesity	7.14e-05	0.000793	CcSEcCtD
Lisinopril—Nasopharyngitis—Topiramate—obesity	7.09e-05	0.000787	CcSEcCtD
Lisinopril—Confusional state—Sibutramine—obesity	7.08e-05	0.000786	CcSEcCtD
Lisinopril—Vision blurred—Bupropion—obesity	7.06e-05	0.000784	CcSEcCtD
Lisinopril—Skin disorder—Orlistat—obesity	7.04e-05	0.000782	CcSEcCtD
Lisinopril—Tremor—Bupropion—obesity	7.02e-05	0.00078	CcSEcCtD
Lisinopril—Gastritis—Topiramate—obesity	7.02e-05	0.000779	CcSEcCtD
Lisinopril—Anaphylactic shock—Sibutramine—obesity	7.02e-05	0.000779	CcSEcCtD
Lisinopril—Oedema—Sibutramine—obesity	7.02e-05	0.000779	CcSEcCtD
Lisinopril—Hyperhidrosis—Orlistat—obesity	7.01e-05	0.000778	CcSEcCtD
Lisinopril—Infection—Sibutramine—obesity	6.97e-05	0.000774	CcSEcCtD
Lisinopril—Ill-defined disorder—Bupropion—obesity	6.95e-05	0.000772	CcSEcCtD
Lisinopril—Anaemia—Bupropion—obesity	6.93e-05	0.000769	CcSEcCtD
Lisinopril—Shock—Sibutramine—obesity	6.9e-05	0.000766	CcSEcCtD
Lisinopril—Thrombocytopenia—Sibutramine—obesity	6.87e-05	0.000763	CcSEcCtD
Lisinopril—Asthma—Topiramate—obesity	6.85e-05	0.000761	CcSEcCtD
Lisinopril—Angioedema—Bupropion—obesity	6.85e-05	0.00076	CcSEcCtD
Lisinopril—Tachycardia—Sibutramine—obesity	6.85e-05	0.00076	CcSEcCtD
Lisinopril—Skin disorder—Sibutramine—obesity	6.82e-05	0.000757	CcSEcCtD
Lisinopril—Eosinophilia—Topiramate—obesity	6.79e-05	0.000753	CcSEcCtD
Lisinopril—Hyperhidrosis—Sibutramine—obesity	6.78e-05	0.000753	CcSEcCtD
Lisinopril—Malaise—Bupropion—obesity	6.76e-05	0.00075	CcSEcCtD
Lisinopril—Vertigo—Bupropion—obesity	6.73e-05	0.000748	CcSEcCtD
Lisinopril—Syncope—Bupropion—obesity	6.72e-05	0.000746	CcSEcCtD
Lisinopril—Pancreatitis—Topiramate—obesity	6.72e-05	0.000746	CcSEcCtD
Lisinopril—Leukopenia—Bupropion—obesity	6.71e-05	0.000745	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—GIP—obesity	6.71e-05	0.00145	CbGpPWpGaD
Lisinopril—Anorexia—Sibutramine—obesity	6.69e-05	0.000743	CcSEcCtD
Lisinopril—Sweating increased—Topiramate—obesity	6.68e-05	0.000741	CcSEcCtD
Lisinopril—Angina pectoris—Topiramate—obesity	6.68e-05	0.000741	CcSEcCtD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—obesity	6.65e-05	0.00144	CbGpPWpGaD
Lisinopril—Palpitations—Bupropion—obesity	6.62e-05	0.000735	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Orlistat—obesity	6.61e-05	0.000733	CcSEcCtD
Lisinopril—Bronchitis—Topiramate—obesity	6.59e-05	0.000732	CcSEcCtD
Lisinopril—Loss of consciousness—Bupropion—obesity	6.59e-05	0.000731	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—GNB3—obesity	6.57e-05	0.00142	CbGpPWpGaD
Lisinopril—Insomnia—Orlistat—obesity	6.56e-05	0.000728	CcSEcCtD
Lisinopril—Hypotension—Sibutramine—obesity	6.56e-05	0.000728	CcSEcCtD
Lisinopril—Cough—Bupropion—obesity	6.54e-05	0.000726	CcSEcCtD
Lisinopril—Paraesthesia—Orlistat—obesity	6.51e-05	0.000723	CcSEcCtD
Lisinopril—Pancytopenia—Topiramate—obesity	6.51e-05	0.000723	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—PCSK1—obesity	6.48e-05	0.00141	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—IGF2—obesity	6.45e-05	0.0014	CbGpPWpGaD
Lisinopril—Dysuria—Topiramate—obesity	6.41e-05	0.000712	CcSEcCtD
Lisinopril—Neutropenia—Topiramate—obesity	6.41e-05	0.000712	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—obesity	6.4e-05	0.00139	CbGpPWpGaD
Lisinopril—Musculoskeletal discomfort—Sibutramine—obesity	6.39e-05	0.00071	CcSEcCtD
Lisinopril—Dyspepsia—Orlistat—obesity	6.38e-05	0.000709	CcSEcCtD
Lisinopril—Myalgia—Bupropion—obesity	6.38e-05	0.000708	CcSEcCtD
Lisinopril—Arthralgia—Bupropion—obesity	6.38e-05	0.000708	CcSEcCtD
Lisinopril—Chest pain—Bupropion—obesity	6.38e-05	0.000708	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Topiramate—obesity	6.37e-05	0.000707	CcSEcCtD
Lisinopril—Anxiety—Bupropion—obesity	6.36e-05	0.000706	CcSEcCtD
Lisinopril—Insomnia—Sibutramine—obesity	6.35e-05	0.000705	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	6.34e-05	0.000704	CcSEcCtD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—obesity	6.32e-05	0.00137	CbGpPWpGaD
Lisinopril—Erectile dysfunction—Topiramate—obesity	6.31e-05	0.000701	CcSEcCtD
Lisinopril—Discomfort—Bupropion—obesity	6.3e-05	0.0007	CcSEcCtD
Lisinopril—Decreased appetite—Orlistat—obesity	6.3e-05	0.0007	CcSEcCtD
Lisinopril—Paraesthesia—Sibutramine—obesity	6.3e-05	0.0007	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Orlistat—obesity	6.26e-05	0.000695	CcSEcCtD
Lisinopril—Dyspnoea—Sibutramine—obesity	6.26e-05	0.000695	CcSEcCtD
Lisinopril—Photosensitivity reaction—Topiramate—obesity	6.26e-05	0.000695	CcSEcCtD
Lisinopril—Fatigue—Orlistat—obesity	6.25e-05	0.000694	CcSEcCtD
Lisinopril—Dry mouth—Bupropion—obesity	6.24e-05	0.000693	CcSEcCtD
Lisinopril—Somnolence—Sibutramine—obesity	6.24e-05	0.000693	CcSEcCtD
Lisinopril—Weight increased—Topiramate—obesity	6.24e-05	0.000692	CcSEcCtD
Lisinopril—Weight decreased—Topiramate—obesity	6.2e-05	0.000688	CcSEcCtD
Lisinopril—Pain—Orlistat—obesity	6.2e-05	0.000688	CcSEcCtD
Lisinopril—Hyperglycaemia—Topiramate—obesity	6.18e-05	0.000686	CcSEcCtD
Lisinopril—Dyspepsia—Sibutramine—obesity	6.18e-05	0.000686	CcSEcCtD
Lisinopril—Confusional state—Bupropion—obesity	6.17e-05	0.000685	CcSEcCtD
Lisinopril—Pneumonia—Topiramate—obesity	6.15e-05	0.000682	CcSEcCtD
Lisinopril—Oedema—Bupropion—obesity	6.12e-05	0.000679	CcSEcCtD
Lisinopril—Anaphylactic shock—Bupropion—obesity	6.12e-05	0.000679	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GABRA6—obesity	6.11e-05	0.00133	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—FTL—obesity	6.11e-05	0.00133	CbGpPWpGaD
Lisinopril—Decreased appetite—Sibutramine—obesity	6.1e-05	0.000677	CcSEcCtD
Lisinopril—Depression—Topiramate—obesity	6.09e-05	0.000676	CcSEcCtD
Lisinopril—Infection—Bupropion—obesity	6.08e-05	0.000675	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Topiramate—obesity	6.06e-05	0.000673	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Sibutramine—obesity	6.06e-05	0.000673	CcSEcCtD
Lisinopril—Shock—Bupropion—obesity	6.02e-05	0.000668	CcSEcCtD
Lisinopril—Renal failure—Topiramate—obesity	6.01e-05	0.000667	CcSEcCtD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—obesity	6.01e-05	0.0013	CbGpPWpGaD
Lisinopril—Constipation—Sibutramine—obesity	6e-05	0.000666	CcSEcCtD
Lisinopril—Pain—Sibutramine—obesity	6e-05	0.000666	CcSEcCtD
Lisinopril—Neuropathy peripheral—Topiramate—obesity	5.99e-05	0.000665	CcSEcCtD
Lisinopril—Thrombocytopenia—Bupropion—obesity	5.99e-05	0.000665	CcSEcCtD
Lisinopril—Feeling abnormal—Orlistat—obesity	5.97e-05	0.000663	CcSEcCtD
Lisinopril—Tachycardia—Bupropion—obesity	5.97e-05	0.000663	CcSEcCtD
Lisinopril—Skin disorder—Bupropion—obesity	5.94e-05	0.00066	CcSEcCtD
Lisinopril—Urinary tract infection—Topiramate—obesity	5.94e-05	0.000659	CcSEcCtD
Lisinopril—Gastrointestinal pain—Orlistat—obesity	5.93e-05	0.000658	CcSEcCtD
Lisinopril—Hyperhidrosis—Bupropion—obesity	5.91e-05	0.000657	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC6A14—obesity	5.86e-05	0.00127	CbGpPWpGaD
Lisinopril—Anorexia—Bupropion—obesity	5.83e-05	0.000647	CcSEcCtD
Lisinopril—Haematuria—Topiramate—obesity	5.83e-05	0.000647	CcSEcCtD
Lisinopril—Feeling abnormal—Sibutramine—obesity	5.78e-05	0.000642	CcSEcCtD
Lisinopril—Epistaxis—Topiramate—obesity	5.76e-05	0.00064	CcSEcCtD
Lisinopril—Urticaria—Orlistat—obesity	5.76e-05	0.000639	CcSEcCtD
Lisinopril—Gastrointestinal pain—Sibutramine—obesity	5.74e-05	0.000637	CcSEcCtD
Lisinopril—Sinusitis—Topiramate—obesity	5.73e-05	0.000637	CcSEcCtD
Lisinopril—Body temperature increased—Orlistat—obesity	5.73e-05	0.000636	CcSEcCtD
Lisinopril—Abdominal pain—Orlistat—obesity	5.73e-05	0.000636	CcSEcCtD
Lisinopril—Hypotension—Bupropion—obesity	5.72e-05	0.000635	CcSEcCtD
Lisinopril—Agranulocytosis—Topiramate—obesity	5.7e-05	0.000633	CcSEcCtD
Lisinopril—Bradycardia—Topiramate—obesity	5.58e-05	0.00062	CcSEcCtD
Lisinopril—Urticaria—Sibutramine—obesity	5.57e-05	0.000619	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Bupropion—obesity	5.57e-05	0.000619	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—GCK—obesity	5.56e-05	0.00121	CbGpPWpGaD
Lisinopril—Body temperature increased—Sibutramine—obesity	5.55e-05	0.000616	CcSEcCtD
Lisinopril—Abdominal pain—Sibutramine—obesity	5.55e-05	0.000616	CcSEcCtD
Lisinopril—Insomnia—Bupropion—obesity	5.53e-05	0.000614	CcSEcCtD
Lisinopril—Rhinitis—Topiramate—obesity	5.5e-05	0.000611	CcSEcCtD
Lisinopril—Paraesthesia—Bupropion—obesity	5.49e-05	0.00061	CcSEcCtD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—GCK—obesity	5.49e-05	0.00119	CbGpPWpGaD
Lisinopril—Hepatitis—Topiramate—obesity	5.49e-05	0.000609	CcSEcCtD
Lisinopril—Hallucination—Topiramate—obesity	5.46e-05	0.000606	CcSEcCtD
Lisinopril—Dyspnoea—Bupropion—obesity	5.45e-05	0.000606	CcSEcCtD
Lisinopril—Pharyngitis—Topiramate—obesity	5.44e-05	0.000604	CcSEcCtD
Lisinopril—Somnolence—Bupropion—obesity	5.44e-05	0.000604	CcSEcCtD
Lisinopril—Urinary tract disorder—Topiramate—obesity	5.42e-05	0.000601	CcSEcCtD
Lisinopril—Oedema peripheral—Topiramate—obesity	5.4e-05	0.0006	CcSEcCtD
Lisinopril—Dyspepsia—Bupropion—obesity	5.38e-05	0.000598	CcSEcCtD
Lisinopril—Urethral disorder—Topiramate—obesity	5.38e-05	0.000597	CcSEcCtD
Lisinopril—Hypersensitivity—Orlistat—obesity	5.34e-05	0.000593	CcSEcCtD
Lisinopril—Decreased appetite—Bupropion—obesity	5.32e-05	0.00059	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—TF—obesity	5.3e-05	0.00115	CbGpPWpGaD
Lisinopril—Gastrointestinal disorder—Bupropion—obesity	5.28e-05	0.000586	CcSEcCtD
Lisinopril—Fatigue—Bupropion—obesity	5.27e-05	0.000586	CcSEcCtD
Lisinopril—Constipation—Bupropion—obesity	5.23e-05	0.000581	CcSEcCtD
Lisinopril—Pain—Bupropion—obesity	5.23e-05	0.000581	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FTL—obesity	5.2e-05	0.00113	CbGpPWpGaD
Lisinopril—Asthenia—Orlistat—obesity	5.2e-05	0.000578	CcSEcCtD
Lisinopril—Erythema multiforme—Topiramate—obesity	5.19e-05	0.000576	CcSEcCtD
Lisinopril—Hypersensitivity—Sibutramine—obesity	5.17e-05	0.000574	CcSEcCtD
Lisinopril—Pruritus—Orlistat—obesity	5.13e-05	0.00057	CcSEcCtD
Lisinopril—Tinnitus—Topiramate—obesity	5.11e-05	0.000568	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—AGT—obesity	5.11e-05	0.00111	CbGpPWpGaD
Lisinopril—Flushing—Topiramate—obesity	5.09e-05	0.000565	CcSEcCtD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—obesity	5.09e-05	0.0011	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—TFRC—obesity	5.08e-05	0.0011	CbGpPWpGaD
Lisinopril—Feeling abnormal—Bupropion—obesity	5.04e-05	0.00056	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—IGFBP1—obesity	5.04e-05	0.00109	CbGpPWpGaD
Lisinopril—Asthenia—Sibutramine—obesity	5.03e-05	0.000559	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—LEP—obesity	5.01e-05	0.00109	CbGpPWpGaD
Lisinopril—Gastrointestinal pain—Bupropion—obesity	5e-05	0.000555	CcSEcCtD
Lisinopril—Angiopathy—Topiramate—obesity	4.98e-05	0.000553	CcSEcCtD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—obesity	4.98e-05	0.00108	CbGpPWpGaD
Lisinopril—Pruritus—Sibutramine—obesity	4.96e-05	0.000551	CcSEcCtD
Lisinopril—Diarrhoea—Orlistat—obesity	4.96e-05	0.000551	CcSEcCtD
Lisinopril—Mediastinal disorder—Topiramate—obesity	4.94e-05	0.000549	CcSEcCtD
Lisinopril—Chills—Topiramate—obesity	4.92e-05	0.000546	CcSEcCtD
Lisinopril—Urticaria—Bupropion—obesity	4.86e-05	0.00054	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC9A3—obesity	4.86e-05	0.00105	CbGpPWpGaD
Lisinopril—Alopecia—Topiramate—obesity	4.85e-05	0.000538	CcSEcCtD
Lisinopril—Abdominal pain—Bupropion—obesity	4.84e-05	0.000537	CcSEcCtD
Lisinopril—Body temperature increased—Bupropion—obesity	4.84e-05	0.000537	CcSEcCtD
Lisinopril—Mental disorder—Topiramate—obesity	4.81e-05	0.000534	CcSEcCtD
Lisinopril—Diarrhoea—Sibutramine—obesity	4.8e-05	0.000533	CcSEcCtD
Lisinopril—Dizziness—Orlistat—obesity	4.79e-05	0.000532	CcSEcCtD
Lisinopril—Malnutrition—Topiramate—obesity	4.78e-05	0.00053	CcSEcCtD
Lisinopril—Erythema—Topiramate—obesity	4.78e-05	0.00053	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—F2—obesity	4.72e-05	0.00102	CbGpPWpGaD
Lisinopril—Flatulence—Topiramate—obesity	4.71e-05	0.000522	CcSEcCtD
Lisinopril—Tension—Topiramate—obesity	4.69e-05	0.00052	CcSEcCtD
Lisinopril—Dysgeusia—Topiramate—obesity	4.68e-05	0.000519	CcSEcCtD
Lisinopril—Dizziness—Sibutramine—obesity	4.64e-05	0.000515	CcSEcCtD
Lisinopril—Nervousness—Topiramate—obesity	4.64e-05	0.000515	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—HK2—obesity	4.63e-05	0.001	CbGpPWpGaD
Lisinopril—Back pain—Topiramate—obesity	4.62e-05	0.000513	CcSEcCtD
Lisinopril—Vomiting—Orlistat—obesity	4.61e-05	0.000512	CcSEcCtD
Lisinopril—Muscle spasms—Topiramate—obesity	4.59e-05	0.00051	CcSEcCtD
Lisinopril—Rash—Orlistat—obesity	4.57e-05	0.000508	CcSEcCtD
Lisinopril—Dermatitis—Orlistat—obesity	4.57e-05	0.000507	CcSEcCtD
Lisinopril—ABCB1—ABC-family proteins mediated transport—APOA1—obesity	4.56e-05	0.00099	CbGpPWpGaD
Lisinopril—Headache—Orlistat—obesity	4.54e-05	0.000504	CcSEcCtD
Lisinopril—Hypersensitivity—Bupropion—obesity	4.51e-05	0.0005	CcSEcCtD
Lisinopril—Vision blurred—Topiramate—obesity	4.5e-05	0.0005	CcSEcCtD
Lisinopril—Tremor—Topiramate—obesity	4.47e-05	0.000497	CcSEcCtD
Lisinopril—Vomiting—Sibutramine—obesity	4.46e-05	0.000495	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC27A1—obesity	4.44e-05	0.000963	CbGpPWpGaD
Lisinopril—Ill-defined disorder—Topiramate—obesity	4.43e-05	0.000492	CcSEcCtD
Lisinopril—Rash—Sibutramine—obesity	4.42e-05	0.000491	CcSEcCtD
Lisinopril—Dermatitis—Sibutramine—obesity	4.42e-05	0.000491	CcSEcCtD
Lisinopril—Anaemia—Topiramate—obesity	4.41e-05	0.00049	CcSEcCtD
Lisinopril—Headache—Sibutramine—obesity	4.4e-05	0.000488	CcSEcCtD
Lisinopril—Asthenia—Bupropion—obesity	4.39e-05	0.000487	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—IGFBP3—obesity	4.38e-05	0.000949	CbGpPWpGaD
Lisinopril—Pruritus—Bupropion—obesity	4.33e-05	0.000481	CcSEcCtD
Lisinopril—Nausea—Orlistat—obesity	4.31e-05	0.000478	CcSEcCtD
Lisinopril—Malaise—Topiramate—obesity	4.31e-05	0.000478	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—POMC—obesity	4.3e-05	0.000934	CbGpPWpGaD
Lisinopril—Vertigo—Topiramate—obesity	4.29e-05	0.000476	CcSEcCtD
Lisinopril—Syncope—Topiramate—obesity	4.28e-05	0.000475	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—INS—obesity	4.28e-05	0.000929	CbGpPWpGaD
Lisinopril—Leukopenia—Topiramate—obesity	4.27e-05	0.000475	CcSEcCtD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—obesity	4.27e-05	0.000926	CbGpPWpGaD
Lisinopril—Palpitations—Topiramate—obesity	4.22e-05	0.000469	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—CCL2—obesity	4.21e-05	0.000914	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—obesity	4.21e-05	0.000913	CbGpPWpGaD
Lisinopril—Loss of consciousness—Topiramate—obesity	4.2e-05	0.000466	CcSEcCtD
Lisinopril—Diarrhoea—Bupropion—obesity	4.19e-05	0.000465	CcSEcCtD
Lisinopril—Nausea—Sibutramine—obesity	4.17e-05	0.000463	CcSEcCtD
Lisinopril—Cough—Topiramate—obesity	4.17e-05	0.000463	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—IGF1—obesity	4.14e-05	0.000898	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NCOA1—obesity	4.12e-05	0.000894	CbGpPWpGaD
Lisinopril—Arthralgia—Topiramate—obesity	4.07e-05	0.000451	CcSEcCtD
Lisinopril—Myalgia—Topiramate—obesity	4.07e-05	0.000451	CcSEcCtD
Lisinopril—Chest pain—Topiramate—obesity	4.07e-05	0.000451	CcSEcCtD
Lisinopril—Anxiety—Topiramate—obesity	4.05e-05	0.00045	CcSEcCtD
Lisinopril—Dizziness—Bupropion—obesity	4.05e-05	0.000449	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	4.04e-05	0.000448	CcSEcCtD
Lisinopril—Discomfort—Topiramate—obesity	4.02e-05	0.000446	CcSEcCtD
Lisinopril—Dry mouth—Topiramate—obesity	3.98e-05	0.000441	CcSEcCtD
Lisinopril—Confusional state—Topiramate—obesity	3.93e-05	0.000436	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CD40—obesity	3.9e-05	0.000847	CbGpPWpGaD
Lisinopril—Oedema—Topiramate—obesity	3.9e-05	0.000433	CcSEcCtD
Lisinopril—Vomiting—Bupropion—obesity	3.89e-05	0.000432	CcSEcCtD
Lisinopril—Infection—Topiramate—obesity	3.87e-05	0.00043	CcSEcCtD
Lisinopril—Rash—Bupropion—obesity	3.86e-05	0.000428	CcSEcCtD
Lisinopril—Dermatitis—Bupropion—obesity	3.85e-05	0.000428	CcSEcCtD
Lisinopril—Shock—Topiramate—obesity	3.83e-05	0.000426	CcSEcCtD
Lisinopril—Headache—Bupropion—obesity	3.83e-05	0.000425	CcSEcCtD
Lisinopril—Thrombocytopenia—Topiramate—obesity	3.82e-05	0.000424	CcSEcCtD
Lisinopril—Tachycardia—Topiramate—obesity	3.8e-05	0.000422	CcSEcCtD
Lisinopril—Skin disorder—Topiramate—obesity	3.79e-05	0.00042	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—TRPV1—obesity	3.78e-05	0.000819	CbGpPWpGaD
Lisinopril—Hyperhidrosis—Topiramate—obesity	3.77e-05	0.000418	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—GHRL—obesity	3.72e-05	0.000807	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—BCHE—obesity	3.72e-05	0.000807	CbGpPWpGaD
Lisinopril—Anorexia—Topiramate—obesity	3.72e-05	0.000412	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HMOX1—obesity	3.71e-05	0.000804	CbGpPWpGaD
Lisinopril—Hypotension—Topiramate—obesity	3.64e-05	0.000404	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—HDAC8—obesity	3.64e-05	0.00079	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—HK1—obesity	3.63e-05	0.000788	CbGpPWpGaD
Lisinopril—Nausea—Bupropion—obesity	3.63e-05	0.000403	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Topiramate—obesity	3.55e-05	0.000394	CcSEcCtD
Lisinopril—Insomnia—Topiramate—obesity	3.53e-05	0.000391	CcSEcCtD
Lisinopril—Paraesthesia—Topiramate—obesity	3.5e-05	0.000389	CcSEcCtD
Lisinopril—Dyspnoea—Topiramate—obesity	3.47e-05	0.000386	CcSEcCtD
Lisinopril—Somnolence—Topiramate—obesity	3.46e-05	0.000385	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—TCF7L2—obesity	3.46e-05	0.000751	CbGpPWpGaD
Lisinopril—Dyspepsia—Topiramate—obesity	3.43e-05	0.000381	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—GCG—obesity	3.4e-05	0.000738	CbGpPWpGaD
Lisinopril—Decreased appetite—Topiramate—obesity	3.39e-05	0.000376	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Topiramate—obesity	3.36e-05	0.000374	CcSEcCtD
Lisinopril—Fatigue—Topiramate—obesity	3.36e-05	0.000373	CcSEcCtD
Lisinopril—Pain—Topiramate—obesity	3.33e-05	0.00037	CcSEcCtD
Lisinopril—Constipation—Topiramate—obesity	3.33e-05	0.00037	CcSEcCtD
Lisinopril—Feeling abnormal—Topiramate—obesity	3.21e-05	0.000357	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC22A1—obesity	3.21e-05	0.000696	CbGpPWpGaD
Lisinopril—Gastrointestinal pain—Topiramate—obesity	3.19e-05	0.000354	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—PLG—obesity	3.16e-05	0.000686	CbGpPWpGaD
Lisinopril—Urticaria—Topiramate—obesity	3.1e-05	0.000344	CcSEcCtD
Lisinopril—Body temperature increased—Topiramate—obesity	3.08e-05	0.000342	CcSEcCtD
Lisinopril—Abdominal pain—Topiramate—obesity	3.08e-05	0.000342	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL10—obesity	2.99e-05	0.000649	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PRKAR2B—obesity	2.96e-05	0.000643	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—GNB3—obesity	2.93e-05	0.000636	CbGpPWpGaD
Lisinopril—Nateglinide—ALB—obesity	2.89e-05	0.0113	CrCbGaD
Lisinopril—ACE—Metabolism of proteins—IGF2—obesity	2.88e-05	0.000625	CbGpPWpGaD
Lisinopril—Hypersensitivity—Topiramate—obesity	2.87e-05	0.000319	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—AQP7—obesity	2.86e-05	0.00062	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—LEP—obesity	2.84e-05	0.000616	CbGpPWpGaD
Lisinopril—Asthenia—Topiramate—obesity	2.8e-05	0.00031	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GCK—obesity	2.79e-05	0.000605	CbGpPWpGaD
Lisinopril—Pruritus—Topiramate—obesity	2.76e-05	0.000306	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—CETP—obesity	2.69e-05	0.000584	CbGpPWpGaD
Lisinopril—Diarrhoea—Topiramate—obesity	2.67e-05	0.000296	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—TF—obesity	2.66e-05	0.000577	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—C3—obesity	2.64e-05	0.000573	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC16A7—obesity	2.61e-05	0.000567	CbGpPWpGaD
Lisinopril—Dizziness—Topiramate—obesity	2.58e-05	0.000286	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—TFRC—obesity	2.55e-05	0.000553	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—obesity	2.52e-05	0.000547	CbGpPWpGaD
Lisinopril—Vomiting—Topiramate—obesity	2.48e-05	0.000275	CcSEcCtD
Lisinopril—Rash—Topiramate—obesity	2.46e-05	0.000273	CcSEcCtD
Lisinopril—Dermatitis—Topiramate—obesity	2.46e-05	0.000273	CcSEcCtD
Lisinopril—Headache—Topiramate—obesity	2.44e-05	0.000271	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—LCN2—obesity	2.43e-05	0.000527	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—obesity	2.37e-05	0.000515	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—obesity	2.36e-05	0.000512	CbGpPWpGaD
Lisinopril—Nausea—Topiramate—obesity	2.31e-05	0.000257	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—COX7C—obesity	2.28e-05	0.000496	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—AGT—obesity	2.28e-05	0.000495	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—LEP—obesity	2.24e-05	0.000485	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—obesity	2.23e-05	0.000484	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—obesity	2.2e-05	0.000477	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A4—obesity	2.17e-05	0.00047	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—CYCS—obesity	2.14e-05	0.000464	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—F2—obesity	2.11e-05	0.000458	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—NCOA1—obesity	2.07e-05	0.000449	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—FTL—obesity	2.07e-05	0.000448	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GABRA6—obesity	2.07e-05	0.000448	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PLG—obesity	2.02e-05	0.000437	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC6A14—obesity	1.98e-05	0.00043	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—POMC—obesity	1.92e-05	0.000417	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—obesity	1.91e-05	0.000415	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—INS—obesity	1.91e-05	0.000415	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CCL2—obesity	1.88e-05	0.000408	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GNB3—obesity	1.87e-05	0.000405	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—HMOX1—obesity	1.86e-05	0.000404	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—IGF1—obesity	1.85e-05	0.000401	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GNAS—obesity	1.82e-05	0.000395	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—obesity	1.79e-05	0.000389	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—APOB—obesity	1.78e-05	0.000387	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CA3—obesity	1.77e-05	0.000383	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IFNG—obesity	1.76e-05	0.000382	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—obesity	1.74e-05	0.000377	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AR—obesity	1.69e-05	0.000366	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC9A3—obesity	1.64e-05	0.000356	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL1B—obesity	1.57e-05	0.00034	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—HK2—obesity	1.57e-05	0.00034	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—obesity	1.55e-05	0.000335	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—obesity	1.54e-05	0.000334	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PPARA—obesity	1.5e-05	0.000326	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GLRX—obesity	1.5e-05	0.000326	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC27A1—obesity	1.5e-05	0.000326	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—APOA1—obesity	1.41e-05	0.000306	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—OTC—obesity	1.34e-05	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—INSIG2—obesity	1.34e-05	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPM1L—obesity	1.34e-05	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ETFDH—obesity	1.34e-05	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—TRPV1—obesity	1.28e-05	0.000277	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—HK1—obesity	1.23e-05	0.000267	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—INPP5E—obesity	1.22e-05	0.000266	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPT—obesity	1.22e-05	0.000266	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UQCRC2—obesity	1.22e-05	0.000266	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TGFB1—obesity	1.22e-05	0.000264	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—obesity	1.16e-05	0.000252	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TNF—obesity	1.14e-05	0.000247	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ME1—obesity	1.14e-05	0.000247	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SUCLG2—obesity	1.14e-05	0.000247	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALDH6A1—obesity	1.14e-05	0.000247	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—obesity	1.13e-05	0.000246	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ALB—obesity	1.12e-05	0.000242	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC22A1—obesity	1.09e-05	0.000235	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UCP1—obesity	1.07e-05	0.000232	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—COX7C—obesity	1.07e-05	0.000232	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PNPLA3—obesity	1.07e-05	0.000232	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—DGAT2—obesity	1.01e-05	0.00022	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CS—obesity	1.01e-05	0.00022	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SUCLA2—obesity	1.01e-05	0.00022	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CPS1—obesity	1.01e-05	0.00022	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—obesity	1e-05	0.000218	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PRKAR2B—obesity	1e-05	0.000217	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—obesity	9.79e-06	0.000212	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MUT—obesity	9.68e-06	0.00021	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LIPE—obesity	9.68e-06	0.00021	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GCK—obesity	9.43e-06	0.000205	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—DGAT1—obesity	9.28e-06	0.000201	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYB5A—obesity	9.28e-06	0.000201	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—CETP—obesity	9.1e-06	0.000197	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—TF—obesity	8.99e-06	0.000195	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ACLY—obesity	8.93e-06	0.000194	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—obesity	8.76e-06	0.00019	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ENPP1—obesity	8.63e-06	0.000187	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALOX12—obesity	8.63e-06	0.000187	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—TFRC—obesity	8.62e-06	0.000187	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HMGCS1—obesity	8.35e-06	0.000181	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—obesity	8.32e-06	0.000181	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PFKFB3—obesity	8.11e-06	0.000176	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PNPLA2—obesity	8.11e-06	0.000176	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PLIN1—obesity	8.11e-06	0.000176	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ACADM—obesity	8.11e-06	0.000176	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ANGPTL4—obesity	8.11e-06	0.000176	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SAT1—obesity	8.11e-06	0.000176	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ACACB—obesity	7.89e-06	0.000171	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—OXCT1—obesity	7.89e-06	0.000171	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYTB—obesity	7.89e-06	0.000171	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PNLIP—obesity	7.69e-06	0.000167	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SRD5A1—obesity	7.69e-06	0.000167	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SDC3—obesity	7.5e-06	0.000163	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP26B1—obesity	7.33e-06	0.000159	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—STS—obesity	7.33e-06	0.000159	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HK2—obesity	7.33e-06	0.000159	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC2A4—obesity	7.33e-06	0.000159	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—CYCS—obesity	7.24e-06	0.000157	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARD—obesity	7.18e-06	0.000156	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	7.1e-06	0.000154	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC27A1—obesity	7.03e-06	0.000153	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—NCOA1—obesity	6.99e-06	0.000152	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GLUL—obesity	6.9e-06	0.00015	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—FABP4—obesity	6.9e-06	0.00015	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PLG—obesity	6.82e-06	0.000148	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ECHS1—obesity	6.54e-06	0.000142	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UCP2—obesity	6.54e-06	0.000142	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HSD11B1—obesity	6.54e-06	0.000142	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UCP3—obesity	6.54e-06	0.000142	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ADH1B—obesity	6.43e-06	0.00014	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPAM—obesity	6.33e-06	0.000137	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARGC1B—obesity	6.33e-06	0.000137	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ACSL1—obesity	6.33e-06	0.000137	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GNB3—obesity	6.32e-06	0.000137	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—HMOX1—obesity	6.29e-06	0.000136	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GNAS—obesity	6.15e-06	0.000133	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—FADS1—obesity	6.15e-06	0.000133	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HADH—obesity	6.15e-06	0.000133	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PCK1—obesity	6.15e-06	0.000133	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—obesity	6.03e-06	0.000131	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—APOB—obesity	6.03e-06	0.000131	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	6.02e-06	0.000131	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ACP5—obesity	5.98e-06	0.00013	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—G6PD—obesity	5.83e-06	0.000126	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SREBF2—obesity	5.76e-06	0.000125	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HK1—obesity	5.76e-06	0.000125	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—obesity	5.62e-06	0.000122	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LPA—obesity	5.56e-06	0.000121	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LPIN1—obesity	5.44e-06	0.000118	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOA5—obesity	5.33e-06	0.000116	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	5.12e-06	0.000111	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC22A1—obesity	5.08e-06	0.00011	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CLOCK—obesity	5.08e-06	0.00011	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PPARA—obesity	5.08e-06	0.00011	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SULT2A1—obesity	4.95e-06	0.000107	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GLP1R—obesity	4.95e-06	0.000107	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—DPYD—obesity	4.87e-06	0.000106	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—APOA1—obesity	4.77e-06	0.000103	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PRKAR2B—obesity	4.69e-06	0.000102	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—DCN—obesity	4.66e-06	0.000101	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CPT1A—obesity	4.53e-06	9.83e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NAMPT—obesity	4.44e-06	9.64e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GCK—obesity	4.42e-06	9.58e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LIPC—obesity	4.42e-06	9.58e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOC3—obesity	4.39e-06	9.52e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CETP—obesity	4.26e-06	9.24e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SDC1—obesity	4.21e-06	9.14e-05	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	4.18e-06	9.07e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKR1C3—obesity	4.14e-06	8.99e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SCARB1—obesity	4.08e-06	8.85e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SREBF1—obesity	3.96e-06	8.59e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GOT2—obesity	3.85e-06	8.36e-05	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ALB—obesity	3.78e-06	8.19e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—FASN—obesity	3.77e-06	8.18e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—BCHE—obesity	3.75e-06	8.14e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP2E1—obesity	3.62e-06	7.86e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NQO1—obesity	3.58e-06	7.77e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC2A4—obesity	3.43e-06	7.45e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GCG—obesity	3.43e-06	7.45e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYCS—obesity	3.39e-06	7.35e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GGT1—obesity	3.33e-06	7.21e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GOT1—obesity	3.33e-06	7.21e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NCOA1—obesity	3.28e-06	7.11e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—STK11—obesity	3.23e-06	7e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP19A1—obesity	3.23e-06	7e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—COMT—obesity	3e-06	6.51e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARGC1A—obesity	2.96e-06	6.42e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GNB3—obesity	2.96e-06	6.42e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HMOX1—obesity	2.95e-06	6.39e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GNAS—obesity	2.88e-06	6.25e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOB—obesity	2.82e-06	6.12e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LPL—obesity	2.69e-06	5.85e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPX1—obesity	2.63e-06	5.7e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CD36—obesity	2.56e-06	5.55e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MTHFR—obesity	2.43e-06	5.26e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARA—obesity	2.38e-06	5.16e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AGT—obesity	2.31e-06	5e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOE—obesity	2.26e-06	4.9e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CAV1—obesity	2.24e-06	4.85e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOA1—obesity	2.23e-06	4.84e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CG—obesity	2.04e-06	4.42e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARG—obesity	1.97e-06	4.27e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—POMC—obesity	1.94e-06	4.21e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—INS—obesity	1.93e-06	4.19e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CD—obesity	1.79e-06	3.89e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALB—obesity	1.77e-06	3.84e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NOS3—obesity	1.69e-06	3.67e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3R1—obesity	1.69e-06	3.67e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CB—obesity	1.56e-06	3.39e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS2—obesity	1.55e-06	3.36e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CA—obesity	9.52e-07	2.07e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKT1—obesity	7.78e-07	1.69e-05	CbGpPWpGaD
